Latest News for: Pharmaceutical sources

Edit

CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference

Pharmiweb 25 Jul 2024
HOUSTON, TX / ACCESSWIRE / July 25, 2024 / CNS Pharmaceuticals, Inc ... Sandra Silberman, MD, PhD, Chief Medical Officer of CNS Pharmaceuticals ... About CNS Pharmaceuticals, Inc ... SOURCE. CNS Pharmaceuticals, Inc.
Edit

MIRA Pharmaceuticals Announces Positive Discovery of Ketamir-2’s Selective NMDA Binding Mechanism of Action

ACCESSWIRE 25 Jul 2024
Latest positive preclinical data provides another step in the path to potential IND submission this year for novel ketamine analog MIAMI, FL / ACCESSWIRE / July 25, 2024 / MIRA Pharmaceuticals, Inc ... MIRA Pharmaceuticals, Inc.
Edit

Actinium Pharmaceuticals (ATNM) Unveils Promising Advances in Targeted Radiotherapies for Cancer Treatment

GetNews 25 Jul 2024
Based on 5 Wall Street analysts offering 12 month price targets for Actinium Pharmaceuticals in the last 3 months ... The average price target represents a 281.32% change from the last price of $7.71 (Source ... Actinium Pharmaceuticals, Inc ... Source..
Edit

MD seizure by DRI sees a three-fold rise in 2022-23

Hindustan Times 25 Jul 2024
“The rising demand for synthetic drugs and the presence of a strong pharmaceutical manufacturing infrastructure make the threat of clandestine manufacturing of such drugs quite significant,” a DRI source said.
Edit

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding ...

ACCESSWIRE 24 Jul 2024
That's the case with Tonix Pharmaceuticals Holding Corp ... Click here for more information on Tonix Pharmaceuticals ... is paid by Tonix Pharmaceuticals Holding Corp ... SOURCE. Tonix Pharmaceuticals Holding Corp.
Edit

Beyond "One Bug, One Drug" - Tonix Pharmaceuticals Secures Up To $34 Million In Funding From The U.S. Department Of Defense To Develop a Broad-Spectrum Antiviral

Pharmiweb 24 Jul 2024
That's the case with Tonix Pharmaceuticals Holding Corp ... Click here for more information on Tonix Pharmaceuticals ... Tonix Pharmaceuticals ... is paid by Tonix Pharmaceuticals Holding Corp ... SOURCE. Tonix Pharmaceuticals Holding Corp.
Edit

Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement

ACCESSWIRE 24 Jul 2024
Kaupinen Founder and CEO, Palvella Therapeutics info@palvellatx.com Media Marcy Nanus Managing Partner, Trilon Advisors, LLC mnanus@trilonadvisors.com Pieris Pharmaceuticals Contact Information Investors info@pieris.com SOURCE.
Edit

Examining progress on volatile organic compound pollution control via the catalytic method

Phys Dot Org 23 Jul 2024
The primary source of VOCs is human production, such as the petrochemical, pharmaceutical and footwear industries, electronic manufacturing, and cooking fumes ... A research team led by Prof. Hongxing Dai and Prof ... More information ... DOI ... Citation ... ....
Edit

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance

ACCESSWIRE 22 Jul 2024
New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, FL / ACCESSWIRE / July 22, 2024 / MIRA Pharmaceuticals, Inc ... MIRA Pharmaceuticals, Inc.
Edit

Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is ...

ACCESSWIRE 17 Jul 2024
CHATHAM, NJ / ACCESSWIRE / July 17, 2024 / With the completion of its final pre-NDA meeting with the FDA, Tonix Pharmaceuticals Holding Corp ... Click here for more information on Tonix Pharmaceuticals ... is paid by Tonix Pharmaceuticals Holding Corp.
Edit

Tonix Pharmaceuticals, Set to File an NDA for Tonmya for the Management of Fibromyalgia, is Planning Expected Launch in 2H 2025

Pharmiweb 17 Jul 2024
CHATHAM, NJ / ACCESSWIRE / July 17, 2024 / With the completion of its final pre-NDA meeting with the FDA, Tonix Pharmaceuticals Holding Corp ... Click here for more information on Tonix Pharmaceuticals ... Tonix Pharmaceuticals ... SOURCE.
Edit

111, Inc. to Participate in Fireside Chat with Water Tower Research on July 18, 2024

The Manila Times 17 Jul 2024
In addition, the Company's online platform, 1 Medicine, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products.
Edit

Insights for Investors: Parenteral Formula Market Expected to Hit USD 12.5 Billion by 2034 with Strategic Growth Opportunities | Future Market Insights, Inc.

Pharmiweb 17 Jul 2024
Lipid emulsion infusion provides a significant energy source, helps avoid high glucose infusion rates, and is required for the delivery of vital fatty acids ... sustainable sourcing, and new formulations.
Edit

CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series

Pharmiweb 16 Jul 2024
HOUSTON, TX / ACCESSWIRE / July 16, 2024 / CNS Pharmaceuticals, Inc ... About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company ... SOURCE. CNS Pharmaceuticals, Inc.
Edit

Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance

ACCESSWIRE 16 Jul 2024
Vital study aligned with FDA guidelines shows encouraging performance as Petros continues close FDA contact for a potential technology-centered Rx-to-OTC switch NEW YORK, NY / ACCESSWIRE / July 16, 2024 / Petros Pharmaceuticals, Inc.

Most Viewed

FILE - An ethereum ATM is seen in Hong Kong, Friday, May 11, 2018. A complex software change enacted Wednesday, Sept. 14, 2022, to the cryptocurrency ethereum holds the potential to dramatically reduce its energy consumption — and resulting climate-related pollution. But the transition known as
AP / Kin Cheung, File
China's Foreign Minister Wang Yi, center, hosts an event for Mahmoud al-Aloul, left, vice chairman of Fatah, and Mussa Abu Marzuk, a senior member of Hamas, to meet at the Diaoyutai State Guesthouse in Beijing, Tuesday, July 23, 2024. (Pedro Pardo/Pool Photo via AP)
AP / Pedro Pardo/Pool Photo via AP
×